Cervical Cancer occurs when abnormal cancer cells develop in the cervix due to exposure to the human papillomavirus (HPV), however not all types of HPV cause cervical cancer. Cervical cancer is the second most common type of cancer in women and the most greatly affects the age groups 35-39 and 60-64. It is frequently found in early stages through the use of pap test. Cervical cancer is commonly treated with chemotherapy, radiation, and surgery to remove pelvic lymph nodes with or without the removal of the ovaries and fallopian tubes. In the most severe cases, hysterectomies may be necessary. Many believe that the HPV vaccine protects against the two types of HPV that cause cervical cancer. In stage III of cervical cancer, the growth has spread into tissues in the pelvic area. Stage III is divided into subgroups IIIA and IIIB where IIIA means that the cancer is located in the lower third of the vagina but not the pelvic wall while IIIB means the growth has progressed through the pelvic wall. In stage IIIB, the tumor may be blocking one or both of the tubes that drain the kidneys. Stage III is frequently treated with chemoradiation.
Stage Iii Cervical Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Stage Iii Cervical Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 1211 products for the study of Stage Iii Cervical Cancer that can be applied to Western Blot, Chromatin Immunoprecipitation, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Chromatin Immunoprecipitation (ChIP) from our catalog of antibodies and ELISA kits.